Research Updates

CureSearch announces new funding commitment to childhood cancer research projects

March 30, 2022 / Press Releases, Research Updates

FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org   CureSearch announces new funding commitment to childhood cancer research projects   Projects will develop new treatments for neuroblastoma, high-grade gliomas, including DMG, and more  Bethesda, Md. – February 15, 2022– CureSearch for Children’s Cancer, a national nonprofit with a mission to end childhood cancer by driving targeted and innovative research with measurable results …

CureSearch announces new funding commitment to childhood cancer research projects Read More »

Elias Sayour, MD, PhD

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial

February 8, 2021 / Childhood Cancer News, CureSearch News, CureSearch Updates, Press Releases, Research in the News, Research Updates

CureSearch for Children’s Cancer receives $1 million gift from Norcross Family Foundation Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma  Bethesda, MD – February 8, 2020  – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing an innovative personalized …

CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »

Delivering measurable results in the form of new treatment options for children today

November 3, 2020 / Blog, Childhood Cancer News, CureSearch Updates, Research Updates

By Caitlyn Barrett, PhD – CureSearch National Director of Research & Programs At CureSearch, we’re focused on driving the most innovative new therapies towards clinical trials where they’ll directly impact children in treatment today. Simply put, if a project can’t reach the clinic in an accelerated timeframe, we don’t fund it. Our strategy is unique, and …

Delivering measurable results in the form of new treatment options for children today Read More »

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research

November 3, 2020 / Press Releases, Research Updates

Contact: Tiffani CopelandSenior Vice President, Development & CommunicationsCureSearch for Children’s CancerEmail: tiffani.copeland@curesearch.org Bethesda, MD – July 30, 2020 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a $225,000 Young Investigator grant to Yale Cancer Center’s Dr. Ranjith Menon Muraleedharan, who will develop a new treatment approach for diffuse intrinsic pontine …

An Innovative Treatment Approach for DIPG: CureSearch for Children’s Cancer Partners with SebastianStrong Foundation to Fund Promising New Research Read More »

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments

November 3, 2020 / Blog, CureSearch Updates, Research Updates

CureSearch Research Funding DrivesNew Brain Cancer Treatments May is National Brain Tumor Awareness Month, highlighting a critical topic in the childhood cancer community as brain cancers account for 25% of all childhood and adolescent cancer diagnoses. Brain tumor types include medulloblastoma (the most common), high- and low-grade glioma, Primitive Neuro-Ectodermal Tumor (PNET), and ependymoma. At CureSearch, we’re dedicated to supporting families affected by brain cancer and to …

CureSearch Research Addresses Critical Unmet Need For Safe, Effective Pediatric Brain Cancer Treatments Read More »

Volunteer Week 2020

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within

November 3, 2020 / Blog, Childhood Cancer News, CureSearch Updates, Research Updates

As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change demands the strategic collaboration of all the players in the pediatric cancer ecosystem, including science, …

National Volunteer Week Spotlight: Industry Advisory Council champions pediatric drug development from within Read More »

Seymour Grant

CureSearch Announces $2.5 Million Grant Supporting First-In-Human Clinical Trial For Pediatric High-Grade Glioma Treatment

November 3, 2020 / Blog, CureSearch Updates, Press Releases, Research Updates

Promising immunotherapy addresses lack of effective treatments for deadly brain tumors Media Contact: Tiffani Copeland Vice President, Campaign Development & Communications CureSearch for Children’s Cancer Email: tiffani.copeland@curesearch.org Phone: (800) 458-6223 Bethesda, MD – March 30, 2020 – CureSearch for Children’s Cancer has committed $2.5 million to fund a first-in-human, phase I/II clinical trial testing an innovative …

CureSearch Announces $2.5 Million Grant Supporting First-In-Human Clinical Trial For Pediatric High-Grade Glioma Treatment Read More »

Coronavirus COVID-19

COVID-19 Impact and Action

November 3, 2020 / Blog, Childhood Cancer News, CureSearch Updates, Research Updates

Updated 5/1/20 To the CureSearch Community: Like you, we’re closely monitoring the evolving situation surrounding COVID-19. With the safety of our patient families, volunteers and staff top of mind, all CureSearch-sponsored events through June 1st have been postponed, including our annual CureSearch Summit and spring Ultimate Hike events. We hope that you’ll continue to participate …

COVID-19 Impact and Action Read More »

Kathryn Lemberg, MD, PhD

Dr. Kathryn Lemberg, CureSearch Young Investigator Award: MPNST

Dr. Kathryn Lemberg – Johns Hopkins University CureSearch Young Investigator Award: 2019-2021 Focus: Malignant Peripheral Nerve Sheath Tumor  Project Title: JHU395: A glutamine antagonist for malignant peripheral nerve sheath tumor Project Overview: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive tumors that arise from the cells that normally support nerve function. Most cases are seen …

Dr. Kathryn Lemberg, CureSearch Young Investigator Award: MPNST Read More »

Pin It on Pinterest

Scroll to Top